Maha FDA's Diwali Spice Shocker: Goods Worth ₹19.70-Crore Seized
1,057 establishments inspected, 84 licences suspended, nearly 12,000 quintals seized. But how much was actually unsafe? 1,053 pending lab reports hold the answer, reports Gajanan Khergamker
Diwali is knocking. Kitchens are gearing up. Chilli, turmeric, coriander and garam masala are flying off the shelves as Maharashtra prepares to spice up its festive feasts. But behind the colourful packets and fragrant powders, the state’s Food and Drug Administration (FDA) has unleashed a sweeping crackdown on the spice trade, putting thousands of quintals of stock under the regulatory scanner.
The numbers are eye-catching. Between April 1 and October 29, 2026, FDA officials inspected 1,057 establishments, collected 1,616 samples, slapped 557 improvement notices and suspended 84 food business licences. The haul? A staggering 11,963.87 quintals of spices and spice products, valued at ₹1,969.51 lakh, or approximately ₹19.70 crore.
And the action went into overdrive just as the festive shopping rush gathered steam. A special drive conducted between October 23 and 29 alone accounted for 472 inspections, 72 licence suspensions and seizures worth ₹1,360 lakh or ₹13.60 crore. In other words, the final week of the operation delivered the lion’s share of the suspensions and seized stock.
 |
| Of the samples analysed so far, 337 were found standard, nine substandard, six unsafe and 18 misbranded |
Licences axed, stock seized. But where’s proof of adulteration?
Here’s where the story needs a closer look. A suspended licence makes headlines, and a ₹19.70-crore seizure makes for an even bigger splash. But neither, by itself, establishes that the spices concerned were adulterated or unsafe to eat.
The FDA’s action was driven largely by unhygienic conditions and violations of Schedule IV of the Food Safety and Standards Act framework. These are serious compliance concerns. Yet a finding of poor hygiene is not the same as a laboratory-confirmed finding that a product is substandard or unsafe.
The laboratory numbers tell their own story. Of the samples analysed so far, 337 were found standard, nine substandard, six unsafe and 18 misbranded. That makes 370 samples with reported outcomes. The remaining 1,053 reports are still pending.
Read that again. More than a thousand laboratory reports remain outstanding. Until those results come in, the full extent of any product-quality violations remains an open question. The distinction matters: Regulatory non-compliance warrants action, but confirmed adulteration must rest on evidence.
Chhatrapati Sambhajinagar leads the seizure scorecard
The crackdown has not been evenly distributed across Maharashtra. Chhatrapati Sambhajinagar emerged as the standout enforcement zone, recording 27 licence suspensions and seizures valued at ₹642.77 lakh. Pune and Konkan followed in terms of seizure value.
Mumbai, meanwhile, was firmly on the FDA’s radar. Brihanmumbai recorded 123 inspections and 10 suspensions, with enforcement activity covering areas including Mumbai Central, Andheri, Bandra, Ghatkopar, Mulund, Dahisar and Bhandup.
There is, however, an administrative wrinkle in the regional listings. Several establishments appear under both Konkan and Thane, reflecting overlapping administrative coverage of the TTC MIDC belt and adjoining areas. The listings need to be read with care before drawing conclusions about the number of distinct businesses targeted across individual jurisdictions.
FDA Chief's Message: Clean up, Label up, Shape up
FDA Commissioner Tukaram Mundhe has directed operators to maintain records identifying the sources of their products, sell spices only in properly labelled packaged form and comply with the October 15 order concerning spices.
 |
| Click on the image to view |
For businesses accustomed to treating paperwork and storage conditions as secondary concerns, the message is unmistakable: Traceability, hygiene and labelling are part of the business, not optional extras to be sorted out after an inspection.
The enforcement tally also includes four compounding cases closed with penalties totalling ₹1.47 lakh, while 13 adjudication cases have been filed. These proceedings represent separate strands of regulatory action, and their eventual outcomes will help establish the consequences faced by the businesses concerned.
Diwali Shopping? Don't let the spice fool you
For consumers, the festive-season lesson is simple: Don't let the colour, aroma or attractive packaging of a spice packet do the talking. A bright red chilli powder or a fragrant blend of garam masala may look enticing, but appearances can be deceptive.
With the FDA tightening its surveillance of the spice trade, shoppers would do well to exercise a little extra caution before stocking up for Diwali. Buy only from licensed sellers and established outlets. Give loose, unlabelled powders a wide berth, however tempting their prices or inviting their appearance.
Check whether the packaging carries the necessary product details, including batch numbers, packing dates and “best before” markings. Damaged, tampered-with or inadequately labelled packets deserve particular scrutiny. Consumers should also be wary of unusually cheap products that promise more than their price or presentation can reasonably justify.
If something looks suspicious, consumers can lodge complaints through the FDA’s toll-free helpline, 1800-222-365, or its complaints portal at complaints.mahafda.in.
The Big Question: What will the lab reports reveal?
The FDA has clearly turned up the heat on Maharashtra’s spice trade ahead of Diwali. Nearly 12,000 quintals of stock have been seized, 84 licences suspended and hundreds of businesses served with improvement notices. The scale of the operation signals a concerted attempt to tighten oversight during a period of peak consumer demand.
But the final verdict on product safety is still pending. Of the 1,423 samples whose status is accounted for in the reported figures, only 370 have received laboratory outcomes so far; 1,053 reports remain awaited. The next critical question is whether those reports establish further instances of substandard or unsafe products, and what enforcement action follows.
For now, a substantial quantity of spice products has been taken out of circulation while the regulatory process runs its course. Whether the crackdown ultimately exposes widespread product-quality violations, or principally demonstrates the consequences of hygiene and licensing failures, will depend on the evidence still to come.
This Diwali, the spice trail has led straight to the regulator’s doorstep. The laboratory results will determine what happens next.
To receive regular updates and notifications, follow The Draft News:
